Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 696 18 601.2 |
| 96 | EP file number | EAKZ | 96 92 3417.8 |
| 86 | WO file number | WAKZ | PCT/US96/10837 |
| 97 | EP publication number | EPN | 840791 |
| 87 | WO publication number | WPN | 1997003203 |
| 54 | Designation/title | TI | HERSTELLUNG VON EINER IMMUNANTWORT GEGEN PROSTAT-SPEZIFISCHES ANTIGEN (PSA) |
| 51 | IPC main class | ICM
(ICMV) | C12N 15/57 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C12N 9/64 (2006.01), C12N 15/86 (2006.01), C07K 16/30 (2006.01), A61K 45/00 (2006.01), A61K 38/43 (2006.01) |
| 22 | DE application date | DAT | Jun 26, 1996 |
| 96 | EP application date | EAT | Jun 26, 1996 |
| 86 | WO application date | WAT | Jun 26, 1996 |
| 43 | Date of first publication | OT | Jan 30, 1997 |
| Date of publication of grant | PET | Jan 16, 2002 |
| 71/73 | Applicant/owner | INH | Therion Biologics Corp., Cambridge, Mass., US; The United States Government as represented by the Department of Health and Human Services, Rockville, Md., US |
| 72 | Inventor | IN | SCHLOM, Jeffrey, Potomac, US; PANICALI, Dennis L., Acton, US |
| 74 | Representative | VTR | Gramm, Lins & Partner Patent- und Rechtsanwälte PartGmbB, 30173 Hannover, DE |
| 10 | Published DE documents | DEPN | Original document:
DE000069618601T2
Searchable text:
DE000069618601T2 |
| Address for service | | Gramm, Lins & Partner Patent- und Rechtsanwälte PartGmbB, 30173 Hannover, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
500306
Jul 10, 1995
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 87 | WO language of publication | WLANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000000840791
Searchable text:
EP000000840791
Original document:
EP000000840791B1
Searchable text:
EP000000840791B1
Original document:
WO001997003203
Searchable text:
WO001997003203 |
| 43 | Date of first publication | EVT | Jan 30, 1997 |
| Date of the first transfer into DPMAregister | EREGT | Sep 28, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Oct 25, 2018
(Show all update days)(Hide all update days)- Oct 25, 2018; Jun 28, 2016; Aug 25, 2015; Aug 14, 2015; Jul 11, 2015; Mar 25, 2015; Jul 24, 2014; Jul 9, 2014; Jul 17, 2013; Jul 10, 2013; Jan 21, 2013
- Historical data not available for this/these date(s)
- Sep 28, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)| INID | Criterion | Field | Content
Close details
|
|---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Dec 5, 2001 |
| 71/73 | Applicant/owner | INH | Therion Biologics Corp., Cambridge, Mass., US; The United States Government as represented by the Department of Health and Human Services, Rockville, Md., US |
| 71/73 | Previous applicant/owner | INHF | Therion Biologics Corp., Cambridge, Mass., US, The United States of America, as represented by the Secretary of the Department of Health and Human Services, Rockville, Md., US |
